Avalo Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-094/9/24 | New | $130,601,986 | $130,601,986 | Equity Only | 06b | SEC linkSEC |
| 2017-05-085/8/17 | New | $5,000,000 | $5,000,000 | Other | 06b | SEC linkSEC |
| 2016-09-169/16/16 | New | $1,000,000 | $1,000,000 | Equity Only | 06b | SEC linkSEC |
| 2014-07-217/21/14 | New | $16,259,016 | $16,259,016 | Equity and Debt | 06b | SEC linkSEC |
| 2013-09-069/6/13 | New | $6,805,883 | $6,805,883 | Equity Only | 06 | SEC linkSEC |
| 2012-04-044/4/12 | New | $22,137,301 | $22,137,301 | Equity Only | 06 | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Thomas Aasen | Director |
| June Almenoff, M.D., Ph.D. | Director |
| Sol J. Barer | Director |
| Eugene A. Bauer | Director |
| Isaac Blech | Director |
| John Catsimatidis | Director |
| Mitchell Chan | Director |
| Bernadine Heather Fraser | Executive |
| Jonathan Goldman, M.D. | Director |
| Phil Gutry | Director |
| Uli Hacksell | Director, Executive |
| John Kaiser | Executive |
| Aaron Kantoff | Director |
| Gilla Kaplan, Ph.D. | Director |
| Karen Krumeich | Executive |
| Ronald Marcus | Executive |
| Reza Mazhari | Executive |
| Mariam E Morris | Executive |
| Garry Neil, M.D. | Director, Executive |
| Federica F. O'brien | Executive |
| Blake M. Paterson | Director, Executive |
| Magnus Persson | Director |
| Magnus Persson, M.D., Ph.D. | Director |
| Sharon Rowland | Executive |
| Behshad Sheldon | Director |
| Cary Sucoff | Director |
| Cary W. Sucoff, Jr. | Director |
| Mayukh Sukhatme | Director |
| Christopher Sullivan | Executive |
| Frank Torti | Director |
| Samantha Truex | Director |
| James Vornov | Executive |
Industry: Biotechnology (See others in industry)
Address:
540 Gaither Road Suite 400
Rockville, MD, 20850
Phone: 410-522-8707
Rockville, MD, 20850
Phone: 410-522-8707